Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Pathologic Complete Response × thymoglobulin × Clear all

Sponsor

Conditions

Leukemia 23 Leukemia, Myeloid, Acute 22 Myelodysplastic Syndromes 21 Leukemia, Lymphocytic, Chronic, B-Cell 17 Precursor Cell Lymphoblastic Leukemia-Lymphoma 16 Lymphoma, Non-Hodgkin 16 Lymphoma 16 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 15 Hodgkin Disease 15 Multiple Myeloma 10 Hematologic Neoplasms 10 Primary Myelofibrosis 9 Myeloproliferative Disorders 9 Lymphoma, Large B-Cell, Diffuse 8 Graft vs Host Disease 8 Lymphoma, Mantle-Cell 7 Lymphoma, Follicular 7 Lymphoma, B-Cell, Marginal Zone 7 Lymphoma, Large-Cell, Immunoblastic 6 Leukemia, Myelomonocytic, Juvenile 6 Leukemia, Myelomonocytic, Chronic 6 Burkitt Lymphoma 6 Leukemia, Myeloid, Accelerated Phase 5 Waldenstrom Macroglobulinemia 4 Lymphoma, T-Cell, Cutaneous 4 Lymphoma, Extranodal NK-T-Cell 4 Leukemia, Neutrophilic, Chronic 4 Leukemia, Myeloid, Chronic-Phase 4 Congenital Abnormalities 4 Blast Crisis 4

Interventions

temsirolimus 1 sargramostim 1 ruxolitinib 1 rucaparib 1 pazopanib 1 olaparib 1 eltrombopag 1 cc-486 1 Surveys and Questionnaires 1 Nivolumab 1 Monatide (IMS 3015) 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Doxorubicin 1 Docetaxel 1 Diphenhydramine 1 Cytarabine 1 Cyclophosphamide 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡